您的购物车当前为空
Tyrosinase-IN-35(compound 6g)作为一种优于Kojic Acid(IC50: 16.38 μM)的人类酪氨酸酶抑制剂(IC50: 2.09 μM),在4 μM及8 μM剂量下已证实可以有效减少黑色素瘤细胞B16F10体外的黑色素含量。

Tyrosinase-IN-35(compound 6g)作为一种优于Kojic Acid(IC50: 16.38 μM)的人类酪氨酸酶抑制剂(IC50: 2.09 μM),在4 μM及8 μM剂量下已证实可以有效减少黑色素瘤细胞B16F10体外的黑色素含量。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 4-6周 | |
| 50 mg | ¥ 13,800 | 4-6周 | |
| 100 mg | ¥ 17,500 | 4-6周 |
Tyrosinase-IN-35 相关产品
| 产品描述 | Tyrosinase-IN-35 (compound 6g), exhibiting a IC 50 value of 2.09 μM, serves as a more effective inhibitor of human tyrosinase compared to Kojic Acid (IC 50: 16.38 μM). At concentrations of 4 μM and 8 μM, this compound effectively lowers melanin levels in melanoma B16F10 cells in vitro. |
| 分子量 | 337.40 |
| 分子式 | C17H15N5OS |
| CAS No. | 1613467-47-2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容